diabetestalk.net

Generic Insulin For Lantus

Share on facebook

Sanofi Moves To Block A Generic Lantus…again

With the move, the drug company seemingly declares to go down with the Lantus ship. Opinion They say the first step to getting yourself out of a hole is to stop digging. At Sanofi, company officials may believe the first step is to fortify and refortify the hole. This month, Sanofi filed a patent lawsuit against fellow drugmaker Merck & Co. to block the latter company from releasing a biosimilar insulin that is supposed to copycat Lantus, according to a FiercePharma report. If this sounds familiar to you, it’s because Sanofi filed a similar lawsuit against Lilly in 2014; that suit was eventually settled in 2015. Lantus is Sanofi’s cornerstone product, a popular long-acting insulin that has been steadily losing marketshare in the face of increased basal insulin competition. For a period of time, Sanofi was able to raise the price of Lantus at will and see their profits rise, but that party began to end in 2015 as insurance payors pushed back against price hikes and Lantus’ marketshare was under siege from increased basal insulin competition. Sanofi first tried defending its position by suing Lilly to block release of a biosimilar. This had the effect of freezing the release of Continue reading >>

Share on facebook

Popular Questions

  1. candlesflame

    CVS Drops Lantus and Replaces it with a Biologic Insulin
    CVS Health has decided to change its formularyCVS Health logo for 2017 and stop covering Sanofi’s Lantus and Toujeo insulin in an effort to fight back against the high cost of the medications and will be replacing Lantus coverage with Eli Lilly’s follow-on biologic insulin Basaglar.
    Ok does anyone here take Biologic Insulin Basglar as its what i will have to change to as in 2017 i can not get my Lantus solo star pen at CVS...would love to hear the good the bad the ugly about this insulin....my other option would be Levemir ???? HELP please any info i saw the web page for Basaglar and it said it was for Drs only...akkkkkkk

  2. msdorenas

    I get my Lantus from CVS but it's through my United Health care coverage. They will still carry it right?

  3. candlesflame

    you need to contact your local CVS acording to the Bloomberg Article and the Newscast CVS now checks every month to see what the wholesale prices of the drugs they carry for 2016 they found the lantus to be overinflated prices like the epi pen and they will drop 35 different cancer meds and Lantus from their shelfs in 2017 its not so much who your health care provider is as who is your pharmacy and will they supply and fill that rx in 2017 the articles i am reading say they will replace Lantus with Biologic Insulin
    CVS Drops Lantus and Replaces it with a Biologic Insulin BASAGLAR i need to get my new dr in 2017 to switch me to Basaglar
    CVS Health has decided to change its formulary for 2017 and stop covering Sanofi’s Lantus and Toujeo insulin in an effort to fight back against the high cost of the medications and will be replacing Lantus coverage with Eli Lilly’s follow-on biologic insulin Basaglar.

  4. -> Continue reading
read more close

Related Articles

  • Lantus Insulin Generic

    The headline you’ve probably read more than once, including here on A Sweet Life, is one of outrage surrounding rumors of price-fixing along with (surprise!) the escalating costs of insulin. People who take insulin rarely switch brands, which means that whatever Big Pharma wants, Big Pharma gets. Insulin is my medical version of water. I don’t go a day without it. So, when I learned about the Open Insulin Project, an evolving group of scienti ...

    insulin Feb 11, 2018
  • Generic Lantus Insulin

    Sanofi hoping to convert patients to Toujeo as Lantus is due to lose U.S. patent protection. (Find the full prescribing info for Toujeo at the bottom of this article.)…. Toujeo is a more potent follow-up to the drugmaker’s top-selling Lantus insulin product, which accounts for a fifth of Sanofi sales. The U.S. Food and Drug Administration late last week approved the once daily, long-acting basal insulin to treat type 1 and type 2 diabetes. An ...

    insulin Feb 13, 2018
  • Lantus Insulin Generic Name

    A A A Medications and Drugs Brand Names: Lantus, Lantus OptiClik Cartridge, Lantus Solostar Pen Generic Name: insulin glargine (Pronunciation: IN su lin AS part, IN su lin AS part PRO ta meen) What is the most important information I should know about insulin glargine (Lantus, Lantus OptiClik Cartridge, Lantus Solostar Pen)? What should I discuss with my healthcare provider before using insulin glargine (Lantus, Lantus OptiClik Cartridge, Lantus ...

    insulin Feb 15, 2018
  • Generic Insulin For Lantus

    Tweet Save There are currently no generic forms of Lantus (insulin glargine) approved in the United States. Lantus is considered a "biologic" medication, and rules and regulations prevent manufacturers from making any generic biologics. Also, patents currently prohibit generic Lantus from being manufactured. The first patent should expire in May 2010, but it is not known when (or if) a generic version of Lantus will become available. Lantus is ma ...

    insulin Apr 22, 2018
  • Is Basaglar Generic For Lantus?

    /PRNewswire/ --The U.S. Food and Drug Administration (FDA) today granted tentative approval for Basaglar (insulin glargine injection), which is indicated to improve glycemic control in adults with type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients with type 1 diabetes. Basaglar is not recommended for the treatment of diabetic ketoacidosis. Basaglar is (NYSE: LLY) and Boehringer Ingelheim's basal insulin, wh ...

    insulin Apr 1, 2018
  • Generic Lantus

    With the move, the drug company seemingly declares to go down with the Lantus ship. Opinion They say the first step to getting yourself out of a hole is to stop digging. At Sanofi, company officials may believe the first step is to fortify and refortify the hole. This month, Sanofi filed a patent lawsuit against fellow drugmaker Merck & Co. to block the latter company from releasing a biosimilar insulin that is supposed to copycat Lantus, accordi ...

    diabetes Jan 20, 2018

Popular Articles

More in insulin